Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (Weighted Average): 2021-2025

Historic Shares Outstanding (Weighted Average) for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $713.5 million.

  • Roivant Sciences' Shares Outstanding (Weighted Average) fell 7.66% to $682.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $682.9 million, marking a year-over-year decrease of 7.66%. This contributed to the annual value of $713.5 million for FY2025, which is 11.45% down from last year.
  • Per Roivant Sciences' latest filing, its Shares Outstanding (Weighted Average) stood at $713.5 million for FY2025, which was down 1.98% from $727.9 million recorded in FY2024.
  • Over the past 5 years, Roivant Sciences' Shares Outstanding (Weighted Average) peaked at $805.8 million during FY2024, and registered a low of $51.3 million during FY2021.
  • For the 3-year period, Roivant Sciences' Shares Outstanding (Weighted Average) averaged around $761.9 million, with its median value being $758.4 million (2023).
  • As far as peak fluctuations go, Roivant Sciences' Shares Outstanding (Weighted Average) surged by 1,248.02% in 2022, and later decreased by 11.45% in 2025.
  • Yearly analysis of 5 years shows Roivant Sciences' Shares Outstanding (Weighted Average) stood at $51.3 million in 2021, then reached $684.8 million in 2021, then skyrocketed by 1,248.02% to $692.1 million in 2022, then increased by 5.93% to $725.4 million in 2022, then grew by 9.59% to $758.4 million in 2023, then grew by 10.82% to $803.9 million in 2023, then rose by 6.25% to $805.8 million in 2024, then declined by 9.45% to $727.9 million in 2024, then dropped by 11.45% to $713.5 million in 2025.